Please be aware that the situation with monkeypox (MPXV) is continuously evolving and as such, advice may change.
JYNNEOS® (modified vaccinia virus Ankara – Bavarian Nordic, MVA-BN) is a vaccine used to prevent infection with smallpox and monkeypox viruses. It is also known as IMVAMUNE® and IMVANEX®. You can read more information about the vaccine
here.
The Ministry of Health is currently working hard to source and distribute JYNNEOS® vaccines, which are thought to have approximately 80% effectiveness on MPXV when a person is fully vaccinated (i.e., when two doses are received, at least 28 days apart). However, there are a number of factors that make these vaccines difficult to source:
· Smallpox was eradicated in the 1980s, and so we have not needed these vaccines for a very long time.
· For this reason, there are very few locations in the world that make the vaccine.
· As global cases of monkeypox have risen, so has demand for the vaccine.
For more information about the vaccine, and to register your interest to receive vaccination, please visit the
ACON website.
Please
do not contact ACON or SHIL directly about receiving a vaccination, as your expression of interest will go to NSW Health for further management. ACON and SHIL are unable to comment or provide information regarding the progress or outcome of your expression of interest. Instead, NSW Health will invite you to book in for your vaccine via SMS.
Please note that ACON and SHIL are also unable to cancel or change any vaccination bookings.
Please note that expressing your interest in receiving a vaccine does not guarantee vaccine access.